Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYBB | P04839 | 1/20 | 0.30 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.30 |
| ▸ | MLYCD | O95822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13310001 | 0.90 | EGFR (0.34) | SMN1; SMN2MLYCD | |
| SCHEMBL3669738 | 0.83 | LSS (0.39) | — | |
| SCHEMBL13310002 | 0.81 | PPARG (0.31) | — | |
| SCHEMBL3424272 | 0.80 | CYP1A2 (0.39) | SMN1; SMN2MLYCD | |
| SCHEMBL11896656 | 0.80 | MLYCD (0.32) | MLYCD | |
| SCHEMBL8899051 | 0.80 | TSHR (0.41) | SMN1; SMN2 | |
| SCHEMBL3221660 | 0.79 | LMNA (0.34) | L3MBTL1SMN1; SMN2MLYCD | |
| SCHEMBL5675150 | 0.79 | NR1I2 (0.43) | L3MBTL1 | |
| SCHEMBL3421882 | 0.79 | L3MBTL1 (0.47) | L3MBTL1CYBBNOX4MLYCD | |
| SCHEMBL8897989 | 0.78 | MAPT (0.46) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2664629-B1 | Functionalised photoinitiators | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| EP-2664629-B1 | Functionalised photoinitiators | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| EP-1711862-B1 | FUNCTIONALIZED PHOTOINITIATORS | BASF SE (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-1711862-B1 | FUNCTIONALIZED PHOTOINITIATORS | BASF SE (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-2664629-A1 | Functionalised photoinitiators | Ciba Holding Inc. (CH) | 2013-11-20 | — | — | EP | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| EP-1711862-A2 | FUNCTIONALIZED PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005076074-A2 | FUNCTIONALIZED PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021126-A1 | Functionalized Photoinitiators | PPOX, TYR, CYP1A1 | L3MBTL1 2782/4885NOX1 491/4885SMN1; SMN2 4226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.